Skip to main content
Article thumbnail
Location of Repository

Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis

By Philip M.W. Bath, Renée H. Martin, Yuko Palesch, Daniel Cotton, Salim Yusuf, Ralph L. Sacco, Hans-Christoph Diener, Danilo Toni, Conrado Estol and Robin Roberts


Background and Purpose—High blood pressure (BP) is common in acute ischemic stroke and associated independently\ud with a poor functional outcome. However, the management of BP acutely remains unclear because no large trials have\ud been completed.\ud \ud Methods—The factorial PRoFESS secondary stroke prevention trial assessed BP-lowering and antiplatelet strategies in\ud 20 332 patients; 1360 were enrolled within 72 hours of ischemic stroke, with telmisartan (angiotensin receptor\ud antagonist, 80 mg/d, n647) vs placebo (n713). For this nonprespecified subgroup analysis, the primary outcome was\ud functional outcome at 30 days; secondary outcomes included death, recurrence, and hemodynamic measures at up to 90\ud days. Analyses were adjusted for baseline prognostic variables and antiplatelet assignment.\ud \ud Results—Patients were representative of the whole trial (age 67 years, male 65%, baseline BP 147/84 mm Hg, small artery disease 60%, NIHSS 3) and baseline variables were similar between treatment groups. The mean time from stroke to recruitment was 58 hours. Combined death or dependency (modified Rankin scale: OR, 1.03; 95% CI, 0.84–1.26; P0.81;\ud death: OR, 1.05; 95% CI, 0.27–4.04; and stroke recurrence: OR, 1.40; 95% CI, 0.68–2.89; P0.36) did not differ between the treatment groups. In comparison with placebo, telmisartan lowered BP (141/82 vs 135/78 mmHg, difference 6 to 7 mmHg and 2 to 4 mmHg; P0.001), pulse pressure (3 to 4 mmHg; P0.002), and rate-pressure product (466 mmHg.bpm; P0.0004).\ud \ud Conclusion—Treatment with telmisartan in 1360 patients with acute mild ischemic stroke and mildly elevated BP appeared\ud to be safe with no excess in adverse events, was not associated with a significant effect on functional dependency, death, or recurrence, and modestly lowered BP

Publisher: American Heart Association Inc
OAI identifier:
Provided by: Nottingham ePrints

Suggested articles


  1. Blood pressure after stroke. A one-year follow-up study.
  2. Blood pressure course in patients with acute stroke and matched controls.
  3. Blood pressure in Acute Stroke Collaboration (BASC). Vasoactive drugs for acute stroke Cochrane Database of Systematic Reviews.
  4. (2000). Calcium antagonists for acute ischemic stroke. Cochrane Database of Systematic Reviews.
  5. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
  6. Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies.
  7. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.
  8. (1996). Evaluation of three devices for self-measurement of blood pressure according to the revised
  9. (2008). for the INTERACT Investigators. Intensive blood pressure reduction in actue cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. doi
  10. for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial.
  11. for the PROFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events.
  12. for the TAIST investigators. Relationship between outcome and baseline blood pressure and other haemodynamic mreasures in acute ischaemic stroke: data from the TAIST trial.
  13. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).
  14. (1995). Group. Post-stroke antihypertensive treatment study. A preliminary result.
  15. Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. doi
  16. High blood pressure in acute stroke and subsequent outcome: a systematic review.
  17. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews.
  18. (1994). INWEST Study Group. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovascular Diseases.
  19. Low dose beta blockade in acute stroke (“BEST” trial): an evaluation.
  20. The ACCESS Study. Evaluation of acute candesartan therapy in stroke survivors.
  21. (2008). The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack doi
  22. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials.
  23. the PROFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
  24. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke.
  25. Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published stroke trials. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.